Keys A. Seven countries: a multivariate analysis of death and coronary heart disease. Cambridge, Mass.: Harvard University Press, 1980.
Dawber TR. The Framingham Study: the epidemiology of atherosclerotic disease. Cambridge, Mass.: Harvard University Press, 1980.
American Heart Association Steering Committee for Medical and Community Program, 1980, Circulation, 62, 449A, 10.1161/01.CIR.62.3.449
Ross, 1986, N Engl J Med, 314, 488, 10.1056/NEJM198602203140806
Martin, 1986, Lancet, 2, 933, 10.1016/S0140-6736(86)90597-0
Barr, 1951, Am J Med, 11, 480, 10.1016/0002-9343(51)90183-0
Nikkilä, 1953, Scand J Clin Lab Invest [Suppl], 5, 1
Miller, 1975, Lancet, 1, 16, 10.1016/S0140-6736(75)92376-4
Miller, 1977, Lancet, 1, 965, 10.1016/S0140-6736(77)92274-7
Gordon, 1977, Am J Med, 62, 707, 10.1016/0002-9343(77)90874-9
Castelli, 1986, JAMA, 256, 2835, 10.1001/jama.1986.03380200073024
Turpeinen, 1979, Int J Epidemiol, 8, 99, 10.1093/ije/8.2.99
Hjermann, 1981, Lancet, 2, 1303, 10.1016/S0140-6736(81)91338-6
Oliver, 1978, Br Heart J, 40, 1069, 10.1136/hrt.40.10.1069
Lipid Research Clinics Program, 1984, JAMA, 251, 365, 10.1001/jama.1984.03340270043026
Peto, 1985, Circulation, 72, III
1976, Proc R Soc Med, 69, 1
Newton RS, Krause BR. Mechanisms of action of gemfibrozil: comparison of studies in the rat to clinical efficacy: In: Fears R, ed. Pharmacological control of hyperlipidaemia. Barcelona, Spain: J.R. Prous, 1986: 171–86.
Nikkilä, 1976, Proc R Soc Med, 69, 58
Olsson, 1976, Proc R Soc Med, 69, 28
Manninen, 1982, Acta Med Scand [Suppl], 668, 82, 10.1111/j.0954-6820.1982.tb08526.x
Glueck, 1983, Am J Cardiol, 52, 31B, 10.1016/0002-9149(83)90655-0
Kesäniemi, 1984, JAMA, 251, 2241, 10.1001/jama.1984.03340410049031
Turner, 1985, Eur J Clin Invest, 15, 100, 10.1111/j.1365-2362.1985.tb00152.x
Saku, 1985, J Clin Invest, 75, 1702, 10.1172/JCI111879
Meinertz, 1986, R Soc Med Int Congr Symp Ser, 87, 15
Weintraub, 1987, J Clin Invest, 79, 1110, 10.1172/JCI112926
Pasternack, 1987, Clin Nephrol, 27, 163
Manninen, 1983, Am J Cardiol, 52, 35B, 10.1016/0002-9149(83)90656-2
Mänttäri, 1987, Eur Heart J, 8, 1, 10.1093/eurheartj/8.suppl_I.1
Wilhelmsen L, Tibblin G, Fodor J, Werkö L. A multifactorial primary prevention trial in Gothenburg, Sweden. In: Larsen OA, Malmborg RO, eds. Coronary heart disease and physical fitness. Copenhagen: Munksgaard, 1971:266–70.
Bortner, 1969, J Chronic Dis, 22, 87, 10.1016/0021-9681(69)90061-7
Simpura J. Scandinavian drinking survey: construction of indices of alcohol intake. Report 46. Oslo: National Institute for Alcohol Research, 1981.
Mäenpää, 1987, Eur Heart J, 8, 31, 10.1093/eurheartj/8.suppl_I.31
Mäenpää, 1987, Eur Heart J, 8, 39, 10.1093/eurheartj/8.suppl_I.39
Friedewald, 1972, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499
Blackburn, 1960, Circulation, 21, 1160, 10.1161/01.CIR.21.6.1160
Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley. 1980.
Lan, 1983, Biometrika, 70, 659, 10.2307/2336502
Lan, 1984, Commun Stat Theory Methods, 13, 2339, 10.1080/03610928408828830
O'Brien, 1979, Biometrics, 35, 549, 10.2307/2530245
Kaplan, 1958, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452
Cancer incidence in Finland 1982. Helsinki, Finland: Cancer Society of Finland, 1986. (Publication no. 34.)
Lipid Research Clinics Program, 1984, JAMA, 251, 351, 10.1001/jama.1984.03340270029025
Rose, 1982, Br Med J, 284, 1600, 10.1136/bmj.284.6329.1600
Frick, 1983, Am J Cardiol, 52, 681, 10.1016/0002-9149(83)90397-1
Canner, 1986, J Am Coll Cardiol, 8, 1245, 10.1016/S0735-1097(86)80293-5
Steinberg, 1985, JAMA, 253, 2080, 10.1001/jama.1985.03350380096029
Åberg, 1985, Atherosclerosis, 54, 89, 10.1016/0021-9150(85)90156-X
Carlson, 1985, Acta Med Scand, 218, 207, 10.1111/j.0954-6820.1985.tb08848.x
Hamsten, 1985, N Engl J Med, 313, 1557, 10.1056/NEJM198512193132501
Leiss, 1985, Metabolism, 34, 74, 10.1016/0026-0495(85)90064-2
